-quin(e)
Compounds with a quinoline core (stem no longer in use).
- Drugs ending in -quin(e): 16
- Approved somewhere: 8
- With a US drug page: 6
- Stem
- -quin(e)
- Class
- Compounds with a quinoline core (stem no longer in use)
- Most common targets
- Ferriprotoporphyrin IX (5), TLR7 (1), TLR9 (1), DNA (1), SLC6A2 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -quin(e), matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Amodiaquine | Approved | Ferriprotoporphyrin IX | Ferriprotoporphyrin IX inhibitor |
| Hydroxychloroquine | Approved | Ferriprotoporphyrin IX, TLR7, TLR9 | Ferriprotoporphyrin IX inhibitor |
| Mefloquine | Approved | Ferriprotoporphyrin IX | Ferriprotoporphyrin IX inhibitor |
| Oxamniquine | Approved | DNA | DNA inhibitor |
| Primaquine | Approved | — | Unknown |
| Tafenoquine | Approved | — | Unknown |
| Chloroquine | Approved | Ferriprotoporphyrin IX | Ferriprotoporphyrin IX inhibitor |
| Debrisoquin | Approved | SLC6A2 | Norepinephrine transporter inhibitor |
| Centhaquine | Phase 3 | — | — |
| Clamoxyquin | Phase 3 | — | — |
| Piperaquine | Phase 3 | Ferriprotoporphyrin IX | Ferriprotoporphyrin IX inhibitor |
| Cabamiquine | Phase 2 | — | — |
| Dimethisoquin | Phase 2 | — | — |
| Flumequine | Phase 2 | — | — |
| Sitamaquine | Phase 2 | — | — |
| Equine umbilical cord mesenchymal stem cells | — | — | Somatic cell supplemental therapy |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO